跳至主要内容
临床试验/NCT06396000
NCT06396000尚未招募不适用

Prolonged Stay in the Pediatric PACU

Saiqiang Guo0 个研究点目标入组 10,000 人开始时间: 2024年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10,000
主要终点
Anesthesia Plan Selection

研究概览

简要总结

The purpose of this study is to determine which factors contribute to prolonged stay of children in the PACU.

详细描述

Studying the factors associated with prolonged stay of children in the PACU is of great significance to the medical team, as it can improve the quality and speed of anesthesia recovery, not only in line with the concept of accelerated rehabilitation surgery, but also through intervention and optimization of specific factors to improve the efficiency of children's postoperative discharge from the PACU, reduce the incidence of complications, lower medical costs, and increase patient and family satisfaction. Therefore, this study aims to explore the factors associated with prolonged stay of children in the PACU through retrospective analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children aged 0-18 years old; Child entering the Pediatric Post-Anesthesia Care.
  • Emergency surgery; Pediatric patients with incomplete medical history; Pediatric patients requiring postoperative ICU care; Pediatric patients with preoperative altered consciousness; Neurological disorders; Severe liver, kidney, lung, and heart diseases.

排除标准

  • 未提供

结局指标

主要结局

Anesthesia Plan Selection

时间窗: Day 1

Anesthesia options include general anesthesia, combined anesthesia, pure intravenous anesthesia, and nerve block anesthesia.

Complications in PACU

时间窗: Day 1

Nausea, vomiting, chills, pain, agitation

The medication usage in PACU

时间窗: Day 1

Morphine, Propofol, Ketorolac, Fentanyl

Pain Score

时间窗: Day 1

Evaluate pain using the Visual Analog Scale (VAS): 0 points: no pain; 1-3 points: mild pain; 4-6 points: moderate pain; 7-10 points: severe pain.

American Society of Anesthesiologists(ASA)

时间窗: Day 1

ASA I: Patients in good health, without systemic disease. ASA II: Patients with mild systemic disease, not significantly limiting daily activity. ASA III: Patients with severe systemic disease, with definite functional limitation. ASA IV: Patients with severe systemic disease that is a constant threat to life. ASA V: Moribund patients who are not expected to survive without the operation. ASA VI: Brain-dead patients whose organs are being removed for donation.

次要结局

  • The use of PCA(Patient-Controlled Analgesia)in PACU(Day 1)

研究者

发起方
Saiqiang Guo
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Saiqiang Guo

Senior nurse

Tongji Hospital

相似试验